Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Clinical trial NCT06350825 · RECRUITING

Trial details

NCT number: NCT06350825
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Therapy, Directly Observed

Start date: 2016-01-01
Primary completion: 2027-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.